Free PANRE Practice Questions

Infectious Disease PANRE practice questions

10 free, board-style Infectious Disease questions for the PANRE, each with the correct answer and a complete explanation. No email, no account required.

Infectious Disease is 7% of the PANRE content blueprint. These questions come from the clinician-reviewed FirstPassPA bank. Attempt each one before you reveal the answer.

Question 1Infectious DiseaseMedium
A 22-year-old college student presents with 5 days of fever, severe sore throat, fatigue, and posterior cervical lymphadenopathy. Examination reveals tonsillar exudates and mild splenomegaly. A heterophile antibody (Monospot) test is positive, and the complete blood count shows atypical lymphocytes. Which of the following medications is most important to avoid in this patient?
  • AIbuprofen
  • BAcetaminophen
  • CAmoxicillin
  • DPrednisone
  • EBenzocaine
Reveal answer & full explanation
Correct answer: C — Amoxicillin
  • AIbuprofen
  • BAcetaminophen
  • CAmoxicillin✓
  • DPrednisone
  • EBenzocaine

Why Amoxicillin is correct

  • The fever, exudative pharyngitis, posterior cervical lymphadenopathy, splenomegaly, positive heterophile test, and atypical lymphocytes establish infectious mononucleosis from Epstein-Barr virus (EBV)
  • Amoxicillin and ampicillin precipitate a widespread maculopapular rash, a transient T-cell-mediated drug-virus reaction, in a substantial minority of patients with acute EBV infection (about 30% in modern amoxicillin series; the classic 80-100% figure comes from older ampicillin data)
  • This drug-virus reaction is not a true IgE-mediated penicillin allergy, but the eruption is striking enough that aminopenicillins are avoided when mononucleosis is suspected
  • The teaching point: confirm or exclude EBV before reflexively prescribing an aminopenicillin for sore throat

Why the others are wrong

  • Acetaminophen — a safe antipyretic/analgesic for symptomatic mononucleosis; chosen by a learner who assumes all medications are hazardous here (confused-with the EBV-aminopenicillin rule)
  • Ibuprofen — also safe for fever and pain; picked by anchoring on a vague "avoid NSAIDs" reflex that does not apply to uncomplicated mononucleosis
  • Prednisone — not contraindicated; it is reserved for specific complications (impending airway obstruction, severe thrombocytopenia, hemolytic anemia) rather than routine use, so "avoid" overstates the caution (right-concept-wrong-drug)
  • Benzocaine — a topical anesthetic in sore-throat lozenges and sprays that is a reasonable symptomatic option for throat pain in adults with mononucleosis; the FDA methemoglobinemia warning bars its use in children younger than 2 years and stresses label dosing in others, so it is not a drug to avoid here (anchoring on a vague drug-safety warning)
Question 2Infectious DiseaseMedium
A 45-year-old woman receiving cytotoxic chemotherapy for breast cancer presents with a single-reading temperature of 38.4°C and feels unwell. Her absolute neutrophil count is 300/µL, and a chest radiograph shows a new right lower lobe consolidation. She is hemodynamically stable. Which of the following is the most appropriate initial management?
  • AOseltamivir
  • BCefepime
  • CFluconazole
  • DCeftriaxone
  • EAmoxicillin-clavulanate
Reveal answer & full explanation
Correct answer: B — Cefepime
  • AOseltamivir
  • BCefepime✓
  • CFluconazole
  • DCeftriaxone
  • EAmoxicillin-clavulanate

Why Cefepime is correct

  • Fever with an absolute neutrophil count below 500/µL defines febrile neutropenia, a medical emergency requiring broad empiric antibiotics within 1 hour
  • The new pulmonary consolidation makes this a high-risk presentation that mandates intravenous therapy
  • Empiric monotherapy is an anti-pseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or a carbapenem), per current IDSA neutropenic-fever guidance
  • Cefepime covers the gram-negative organisms, including Pseudomonas, that drive early mortality in neutropenic patients

Why the others are wrong

  • Oseltamivir — an anti-influenza agent with no bacterial coverage; chosen by buzzword-matching the pulmonary infiltrate to a viral pneumonia without addressing the neutropenia
  • Fluconazole — antifungal therapy is added later for persistent fever despite broad antibacterials, not as first-line empiric coverage (right-concept-wrong-timing)
  • Amoxicillin-clavulanate — the oral component of a low-risk OUTPATIENT regimen (with ciprofloxacin); inappropriate here because the consolidation and inpatient status make this high-risk (premature closure on a "stable" patient)
  • Ceftriaxone — the right lower lobe consolidation invites a community-acquired pneumonia regimen, but ceftriaxone lacks anti-pseudomonal activity, and febrile neutropenia requires an anti-pseudomonal beta-lactam such as cefepime (right-class-wrong-generation)
Question 3Infectious DiseaseMedium
A 45-year-old man with HIV (CD4 count 45 cells/µL, not on antiretroviral therapy) develops painless, progressive visual changes, including floaters and a curtain-like loss of vision. Ophthalmologic examination shows hemorrhagic retinal lesions with perivascular exudates in a 'pizza pie' pattern. Which of the following is the most likely diagnosis?
  • AHIV-associated retinopathy
  • BCryptococcal chorioretinitis
  • CToxoplasma retinochoroiditis
  • DAcute retinal necrosis
  • ECytomegalovirus retinitis
Reveal answer & full explanation
Correct answer: E — Cytomegalovirus retinitis
  • AHIV-associated retinopathy
  • BCryptococcal chorioretinitis
  • CToxoplasma retinochoroiditis
  • DAcute retinal necrosis
  • ECytomegalovirus retinitis✓

Why Cytomegalovirus retinitis is correct

  • CMV retinitis is the most common ocular opportunistic infection in advanced AIDS and characteristically appears once the CD4 count falls below 50 cells/µL, as in this patient.
  • The painless, progressive floaters and a curtain of vision loss reflect full-thickness necrotizing retinitis.
  • The 'pizza pie' fundus — hemorrhage plus perivascular exudates and necrosis — is the classic sign.
  • Management is systemic valganciclovir (with intravitreal ganciclovir for sight-threatening lesions) plus prompt antiretroviral therapy.

Why the others are wrong

  • Cryptococcal chorioretinitis — Cryptococcus in AIDS causes meningitis and, rarely, papilledema, not hemorrhagic 'pizza pie' retinitis; picking it confuses the feared CNS opportunist with the ocular one (buzzword-matching on HIV).
  • Acute retinal necrosis — a VZV/HSV peripheral necrotizing retinitis that is typically painful with prominent anterior-chamber and vitreous inflammation and occurs in immunocompetent hosts; the painless course and CD4 <50 point away (premature closure on 'viral retinitis').
  • Toxoplasma retinochoroiditis — produces a focal yellow-white 'headlight in the fog' lesion next to an old chorioretinal scar with dense vitritis, not diffuse hemorrhagic perivascular exudates (confused-with-CMV trap).
  • HIV-associated retinopathy — a common retinal finding in advanced HIV, with cotton-wool spots and small intraretinal hemorrhages that can mimic early CMV, but it is a noninfectious microvasculopathy that is usually asymptomatic and nonprogressive rather than a necrotizing retinitis with floaters and expanding vision loss (look-alike trap).

Teaching point

  • In AIDS with CD4 <50, painless visual loss and a hemorrhagic 'pizza pie' retina is CMV retinitis until proven otherwise.
Question 4Infectious DiseaseMedium
A 32-year-old man develops fever, night sweats, and tender bilateral inguinal lymphadenopathy three weeks after unprotected intercourse. He recalls a small, painless penile ulcer that has since healed. Nucleic acid amplification testing of an inguinal lymph node aspirate is positive for Chlamydia trachomatis. Which of the following is the most likely diagnosis?
  • ALymphogranuloma venereum
  • BGranuloma inguinale
  • CChancroid
  • DPrimary syphilis
  • EPrimary genital herpes
Reveal answer & full explanation
Correct answer: A — Lymphogranuloma venereum
  • ALymphogranuloma venereum✓
  • BGranuloma inguinale
  • CChancroid
  • DPrimary syphilis
  • EPrimary genital herpes

Why Lymphogranuloma venereum is correct

  • Caused by the invasive Chlamydia trachomatis serovars L1-L3; a positive C. trachomatis NAAT from a lymph node aspirate plus a compatible syndrome is enough to diagnose and treat, because serovar genotyping is not widely available
  • Classic course: a small painless primary ulcer (often already healed) followed by painful, tender inguinal lymphadenopathy (buboes)
  • The 'groove sign' occurs when adenopathy forms both above and below the inguinal ligament

Why the others are wrong

  • Chancroid — Haemophilus ducreyi causes a painful (not painless) genital ulcer with tender adenopathy, but the node aspirate would not be positive for C. trachomatis (premature closure on 'painful ulcer with nodes')
  • Granuloma inguinale — Klebsiella granulomatis causes progressive beefy-red ulcerative lesions without true buboes (buzzword-matching on tropical STI)
  • Primary syphilis — Treponema pallidum produces a painless chancre with nontender, rubbery regional nodes rather than tender buboes, and would not yield a C. trachomatis-positive node aspirate (anchoring on 'painless ulcer = syphilis')
  • Primary genital herpes — primary herpes simplex infection does cause fever, malaise, and tender bilateral inguinal lymphadenopathy, but its lesions are multiple painful vesicles that erode into shallow ulcers, the adenopathy accompanies the active lesions rather than following a healed painless ulcer by weeks, and the node aspirate would not be positive for C. trachomatis (anchoring on 'fever with tender bilateral nodes')

Additional high-yield points

  • Rectal LGV (common in men who have sex with men): proctitis, rectal pain, bloody discharge
  • Treatment: doxycycline 100 mg twice daily for 21 days; test and treat partners
  • Fluctuant buboes may be aspirated through intact skin or incised and drained to prevent inguinal or femoral ulceration (CDC 2021)
Question 5Infectious DiseaseMedium
A 45-year-old previously healthy man who lives in Tucson, Arizona, has had fever, dry cough, pleuritic chest pain, and marked fatigue for 3 weeks. Ten days ago an urgent care clinician diagnosed community-acquired pneumonia and prescribed amoxicillin 1 g three times daily for 7 days, which he completed without improvement. A complete blood count at that visit showed 10% eosinophils; today the white blood cell count is 8,600/uL with 14% eosinophils. A plain film of the chest shows a segmental consolidation in the right middle lobe. Which of the following is the most likely diagnosis?
  • APulmonary blastomycosis
  • BCoccidioidal pneumonia
  • CMycoplasma pneumonia
  • DPneumococcal pneumonia
  • EPrimary tuberculosis
Reveal answer & full explanation
Correct answer: B — Coccidioidal pneumonia
  • APulmonary blastomycosis
  • BCoccidioidal pneumonia✓
  • CMycoplasma pneumonia
  • DPneumococcal pneumonia
  • EPrimary tuberculosis

Why Coccidioidal pneumonia is correct

  • Coccidioides immitis and C. posadasii live in the soil of the desert Southwest (Arizona, especially the Phoenix and Tucson areas, and California's San Joaquin Valley); residents can be infected simply by breathing airborne spores, so a specific high-risk activity such as digging is not needed, and symptoms begin about 1-3 weeks after arthroconidia are inhaled
  • Primary coccidioidal pneumonia (Valley fever) is a subacute illness with fever, cough, pleuritic chest pain, and marked fatigue that often lasts weeks; the film usually shows a unilateral segmental or lobar consolidation, most often perihilar or basilar but possible in any lobe (the right middle lobe here), and it looks like any bacterial community-acquired pneumonia, so it is commonly treated as one first
  • Two findings point to it here: no improvement after a full, guideline-appropriate antibacterial course, and peripheral eosinophilia that was already present before the amoxicillin was started (more than 5% should raise suspicion for coccidioidomycosis), which the other choices do not typically cause
  • In endemic areas it is a common cause of outpatient pneumonia: coccidioidal infection accounted for 24% of newly diagnosed community-acquired pneumonia in ambulatory patients in two small Arizona studies cited by IDSA 2016

Why the others are wrong

  • Mycoplasma pneumonia - the strongest bacterial rival: it causes a gradual, subacute illness with a nagging dry cough and a usually normal white count, and amoxicillin does not treat it because Mycoplasma has no cell wall; but it does not explain peripheral eosinophilia, and in a Tucson resident whose pneumonia has failed antibacterial therapy, coccidioidomycosis is the more likely cause (the trap is assuming that failure of a beta-lactam must mean an atypical bacterium)
  • Pneumococcal pneumonia - the most common bacterial cause of a lobar infiltrate, but it typically begins abruptly with rigors and productive sputum and usually raises the neutrophil count, and amoxicillin 1 g three times daily (an ATS/IDSA 2019 first-line outpatient regimen for healthy adults) is active against most strains; a 3-week illness with a normal white count and eosinophilia that did not improve after a full course does not fit (the trap is premature closure on the most common cause of cough plus infiltrate)
  • Primary tuberculosis - TB belongs on the differential of a pneumonia that does not resolve on standard antibiotics, and primary TB can produce a middle- or lower-lobe infiltrate like this one, but nothing here suggests a TB exposure and peripheral eosinophilia is not a feature of tuberculosis; reactivation TB, the usual adult form, favors the upper lobes with cavitation (the trap is jumping to TB for every nonresolving pneumonia without weighing local epidemiology)
  • Pulmonary blastomycosis - like coccidioidomycosis, acute pulmonary blastomycosis can produce a segmental or lobar consolidation that mimics bacterial community-acquired pneumonia and does not respond to antibacterial therapy, but Blastomyces is endemic around the Great Lakes and the Ohio and Mississippi River basins rather than the desert Southwest, and it does not typically cause peripheral eosinophilia (the trap is recognizing an endemic mycosis without matching the fungus to its geography)

Additional high-yield points

  • Consider coccidioidomycosis in every patient with community-acquired pneumonia who lives in or has recently traveled to an endemic area, not only after antibiotics fail; repeated empiric antibacterial courses delay the diagnosis
  • Confirm with serology: enzyme immunoassay for IgM and IgG, confirmed by immunodiffusion, with complement fixation titers to track disease burden (a titer above 1:16 suggests more extensive disease or dissemination); early serology can be negative, so repeat it in 2-4 weeks when suspicion persists
  • Erythema nodosum and arthralgias (desert rheumatism) support the diagnosis when present and signal a lower risk of dissemination, but many patients with coccidioidal pneumonia have neither, so their absence does not argue against it
  • Most immunocompetent patients with uncomplicated primary infection recover with observation and follow-up; fluconazole is used for debilitating or prolonged illness (symptoms > 2 months, weight loss > 10%, extensive infiltrates) or a high risk of severe or disseminated disease (immunosuppression, diabetes, third-trimester pregnancy, African or Filipino ancestry); amphotericin B is used for severe or rapidly progressive disease and in first-trimester pregnancy, when azoles are avoided as teratogens
  • Dissemination (skin, bones and joints, meninges) is uncommon; coccidioidal meningitis requires lifelong azole therapy
  • Geography of the endemic mycoses: Coccidioides in the desert Southwest; Histoplasma in the Ohio and Mississippi River valleys (bird or bat droppings); Blastomyces around the Great Lakes and the Ohio and Mississippi River basins (wooded riverbanks), classically with verrucous skin lesions
Question 6Infectious DiseaseMedium
A 35-year-old male healthcare worker sustains a needlestick from a patient known to be HIV positive (viral load 50,000 copies/mL). Exposure occurred 2 hours ago. Which of the following is the most appropriate post-exposure prophylaxis?
  • AZidovudine/lamivudine plus nevirapine for 28 days
  • BTenofovir/emtricitabine plus dolutegravir for 28 days
  • CTenofovir/emtricitabine plus darunavir/ritonavir for 28 days
  • DTenofovir/emtricitabine/efavirenz for 28 days
  • EAbacavir/lamivudine plus dolutegravir for 28 days
Reveal answer & full explanation
Correct answer: B — Tenofovir/emtricitabine plus dolutegravir for 28 days
  • AZidovudine/lamivudine plus nevirapine for 28 days
  • BTenofovir/emtricitabine plus dolutegravir for 28 days✓
  • CTenofovir/emtricitabine plus darunavir/ritonavir for 28 days
  • DTenofovir/emtricitabine/efavirenz for 28 days
  • EAbacavir/lamivudine plus dolutegravir for 28 days

Why Tenofovir/emtricitabine plus dolutegravir for 28 days is correct

  • HIV post-exposure prophylaxis (PEP) should start as soon as possible, ideally within 2 hours and no later than 72 hours post-exposure
  • Transmission risk from a needlestick of an HIV+ source is approximately 0.3% without PEP; PEP reduces transmission by approximately 80%
  • Preferred regimens (2025 US Public Health Service occupational PEP guideline): bictegravir/emtricitabine/tenofovir alafenamide, or dolutegravir plus tenofovir (TDF or TAF) plus emtricitabine or lamivudine, for 28 days; raltegravir-based regimens are no longer preferred

Why the others are wrong

  • Tenofovir/emtricitabine/efavirenz for 28 days — efavirenz-based regimens are no longer preferred due to neuropsychiatric side effects
  • Zidovudine/lamivudine plus nevirapine for 28 days — nevirapine is avoided for PEP because of hepatotoxicity
  • Tenofovir/emtricitabine plus darunavir/ritonavir for 28 days — darunavir/ritonavir is an alternative anchor but is not the preferred agent
  • Abacavir/lamivudine plus dolutegravir for 28 days — dolutegravir is a preferred anchor, which makes this familiar treatment regimen tempting, but abacavir requires HLA testing before the first dose to exclude carriers at risk of a potentially fatal hypersensitivity reaction, and waiting for that result delays a time-critical start, so abacavir is not used for routine PEP

Additional high-yield points

  • Follow-up HIV testing: 4th-generation antigen/antibody test at baseline, then final testing at 12 weeks with a laboratory antigen/antibody test plus an HIV nucleic acid test; interim testing at 4-6 weeks is added only if PEP started more than 24 hours after exposure or doses were missed, and 6-month testing is no longer recommended
Question 7Infectious DiseaseMedium
A 52-year-old previously healthy hunter from Minnesota is admitted with biopsy-confirmed pulmonary and cutaneous blastomycosis. He has moderate pulmonary involvement with a peak oxygen requirement of 2 L by nasal cannula and several verrucous skin lesions but no CNS involvement. His liver and renal function are normal and he is hemodynamically stable. Which of the following is the most appropriate first-line management?
  • AObservation with serial imaging
  • BOral fluconazole for 4 weeks
  • COral itraconazole for 6-12 months
  • DOral ketoconazole for 6-12 months
  • EIV caspofungin for 2-4 weeks
Reveal answer & full explanation
Correct answer: C — Oral itraconazole for 6-12 months
  • AObservation with serial imaging
  • BOral fluconazole for 4 weeks
  • COral itraconazole for 6-12 months✓
  • DOral ketoconazole for 6-12 months
  • EIV caspofungin for 2-4 weeks

Why Oral itraconazole for 6-12 months is correct

  • The Infectious Diseases Society of America (IDSA) recommends oral itraconazole 200 mg twice daily for 6-12 months as first-line therapy for mild-to-moderate non-CNS blastomycosis
  • Itraconazole has excellent activity against Blastomyces dermatitidis, good tissue penetration, and proven cure rates exceeding 90% in non-severe disease
  • Serum drug levels should be monitored after 2 weeks to confirm therapeutic concentrations

Why the others are wrong

  • Observation with serial imaging — observation is inappropriate because untreated blastomycosis carries substantial morbidity and mortality with risk of dissemination to bone, GU tract, and CNS
  • Oral fluconazole for 4 weeks — fluconazole has weaker in vitro and clinical activity against Blastomyces and is reserved for CNS disease as part of step-down therapy or when itraconazole cannot be used; a 4-week course is inadequate regardless
  • Oral ketoconazole for 6-12 months — ketoconazole is active against Blastomyces and was used before itraconazole, but it appears less effective, relapses more often, and is more toxic; since 2013 the FDA has restricted oral ketoconazole to endemic mycoses only when safer antifungals are unavailable or not tolerated (hepatotoxicity, adrenal insufficiency, drug interactions), so it is never first-line
  • IV caspofungin for 2-4 weeks — echinocandins are tempting as well-tolerated IV antifungals for a hospitalized patient, but they have poor activity against Blastomyces and the other dimorphic endemic fungi and have no role in treating blastomycosis

Additional high-yield points

  • For severe pulmonary, disseminated, or CNS disease: liposomal amphotericin B is given for 1-2 weeks followed by itraconazole step-down therapy
Question 8Infectious DiseaseMedium
A 7-year-old girl is brought back to clinic for 5 days of perianal itching that wakes her at night. Five weeks ago a cellophane tape test showed Enterobius vermicularis eggs, and she was given a single dose of pyrantel pamoate, after which her itching resolved. She lives with her parents and two brothers, and no one in the home is pregnant. Her 4-year-old brother has now begun scratching his perianal area at night; her 10-year-old brother and both parents have no symptoms. A tape test today again shows the characteristic eggs. In addition to hygiene measures, which of the following pyrantel pamoate regimens is most appropriate?
  • AOnce daily for 3 consecutive days for the two symptomatic children
  • BOnce daily for 3 consecutive days for everyone living in the home
  • CSingle dose now for everyone living in the home, repeated if itching recurs
  • DSingle dose now and again at 2 weeks for everyone living in the home
  • ESingle dose now and again at 2 weeks for the two symptomatic children
Reveal answer & full explanation
Correct answer: D — Single dose now and again at 2 weeks for everyone living in the home
  • AOnce daily for 3 consecutive days for the two symptomatic children
  • BOnce daily for 3 consecutive days for everyone living in the home
  • CSingle dose now for everyone living in the home, repeated if itching recurs
  • DSingle dose now and again at 2 weeks for everyone living in the home✓
  • ESingle dose now and again at 2 weeks for the two symptomatic children

Why Single dose now and again at 2 weeks for everyone living in the home is correct

  • Itching returned about a month after one dose, and a second household member now has symptoms: this is ongoing transmission within the family (reinfection), not drug failure, so the same drug is used again.
  • Pyrantel pamoate, albendazole, and mebendazole kill worms in the gut but cannot kill eggs; eggs swallowed around the time of a dose hatch afterward and grow into egg-laying adults in about a month.
  • The CDC regimen is therefore a single dose followed by a second dose of the same drug 2 weeks later, which kills the worms that were still eggs at the first dose before they can lay eggs of their own; her first course stopped after dose one.
  • CDC advises treating everyone in the household, and the caregivers of the diagnosed child, at the same time; the AAP Red Book likewise supports treating the household together when several members are infected or infections recur - both apply here.
  • Pinworm is often asymptomatic, so the parents and older brother may carry worms and reseed the children; they are treated without first needing their own tape tests.
  • Pyrantel pamoate is sold over the counter and dosed at 11 mg/kg (maximum 1 g) for each person, adults included, at both time points.

Why the others are wrong

  • Single dose now and again at 2 weeks for the two symptomatic children - the schedule is right, but pinworm carriers are often itch-free; with two infected members, untreated asymptomatic parents or the 10-year-old keep seeding eggs onto fingers, bedding, and shared surfaces, and the children are reinfected (the trap is treating only the people who are itching).
  • Once daily for 3 consecutive days for everyone living in the home - the right people, but all three doses land within the same few days; they kill the worms present now and miss the worms that hatch from eggs swallowed around that time, which mature after the last dose and restart the household cycle about a month later; a 3-day pyrantel course is a CDC regimen for hookworm, not pinworm (the trap is assuming more consecutive doses make a more thorough course).
  • Once daily for 3 consecutive days for the two symptomatic children - this combines both errors: the three doses fall too close together to reach the next generation of worms, and the asymptomatic parents and 10-year-old are left untreated to reinfect the children.
  • Single dose now for everyone living in the home, repeated if itching recurs - the right drug for the right people, but the 2-week dose is scheduled, not held for symptoms: worms that hatch from eggs swallowed around the first dose mature and lay eggs before itching returns, so by the time a repeat is triggered the household cycle has restarted, exactly as it did after her single dose (the trap is treating the second dose as optional).

Additional high-yield points

  • The 2-week dose is scheduled, not held until symptoms return: by the time itching recurs, new females are already laying eggs around the anus and the household cycle has restarted - the pattern this girl shows after her single dose.
  • Recurrence after treatment usually reflects reinfection, so retreat with the same agent. Albendazole (400 mg) and mebendazole (100 mg) are equally acceptable first-line choices, each given as one dose repeated at 2 weeks.
  • Mechanism: pyrantel is a depolarizing neuromuscular blocker that causes spastic paralysis of the worm, which is then passed in stool; albendazole and mebendazole bind parasite beta-tubulin and block microtubule assembly.
  • A pregnant household contact is not treated automatically with the rest of the family: CDC advises considering treatment in pregnancy only when the infection is compromising the pregnancy (for example, weight loss or sleeplessness), and even then withholding it until the third trimester, when any risk to the fetus is likely lower. For a child younger than 2 years, CDC advises weighing risks and benefits before treating.
  • Hygiene: bathe in the morning to remove eggs laid overnight, change underwear daily, keep nails short, wash hands with soap and warm water and scrub under the nails, discourage scratching and nail biting, and launder bedding and clothing in hot water; eggs can survive on objects for 2 to 3 weeks.
  • Daycare or institutional outbreaks follow the same rule: mass, simultaneous treatment, repeated 2 weeks later.
  • Diagnosis is the tape test done in the morning before bathing or defecation; one test detects about 50% of infections and tests on 3 mornings about 90%. Stool ova and parasites testing is insensitive, and eosinophilia is usually absent because the worm does not invade tissue.
Question 9Infectious DiseaseMedium
A 35-year-old man who recently emigrated from sub-Saharan Africa was diagnosed with HIV and cryptococcal meningitis 8 weeks ago, when his CD4 count was 28 cells/mm^3, CSF opening pressure was 32 cmH2O, CSF white cell count was 6/mm^3, and CSF cryptococcal antigen titer was 1:2048. His symptoms resolved with 2 weeks of liposomal amphotericin B plus flucytosine, and he has continued fluconazole with confirmed adherence. Antiretroviral therapy (ART) was started 5 weeks after antifungal therapy began. Three weeks later he returns with fever, recurrent headache, and neck stiffness. His CD4 count is now 118 cells/mm^3, and his HIV RNA has fallen from 310,000 to 420 copies/mL. Repeat lumbar puncture shows an opening pressure of 30 cmH2O, 95 white cells/mm^3 (80% lymphocytes), glucose 56 mg/dL (serum 98 mg/dL), and protein 88 mg/dL. CSF cryptococcal antigen titer is 1:128, and CSF fungal culture shows no growth. Which of the following is the most likely diagnosis?
  • AParadoxical cryptococcal IRIS
  • BActive tuberculous meningitis
  • CDrug-induced aseptic meningitis
  • DRelapsed cryptococcal infection
  • EUnmasking cryptococcal IRIS
Reveal answer & full explanation
Correct answer: A — Paradoxical cryptococcal IRIS
  • AParadoxical cryptococcal IRIS✓
  • BActive tuberculous meningitis
  • CDrug-induced aseptic meningitis
  • DRelapsed cryptococcal infection
  • EUnmasking cryptococcal IRIS

Why Paradoxical cryptococcal IRIS is correct

  • Immune reconstitution inflammatory syndrome (IRIS) is an inflammatory response against pathogen antigen as immunity recovers on ART; the paradoxical form is a flare of an opportunistic infection that was already diagnosed and improving on treatment
  • This patient improved on induction therapy, then deteriorated 3 weeks after ART began, in step with a CD4 rise from 28 to 118 cells/mm^3 and a nearly 3-log fall in HIV RNA; paradoxical cryptococcal IRIS typically appears within the first 1-3 months of ART
  • The CSF now shows far more inflammation than at diagnosis (95 vs 6 white cells/mm^3) with raised opening pressure, yet the fungal culture is sterile: inflammation without viable organisms. The antigen is still detectable because cryptococcal antigen clears slowly after successful therapy, so its presence does not signal live yeast
  • He carried the classic risk factors: very low CD4 count and high HIV RNA before ART, a high baseline antigen titer, and a scant CSF white cell response at diagnosis

Why the others are wrong

  • Active tuberculous meningitis — TB often surfaces in the first months of ART in patients from high-burden regions and also gives a lymphocytic CSF, but tuberculous meningitis usually lowers CSF glucose (CSF:serum ratio <0.5) and raises protein markedly (often 100-500 mg/dL); here the ratio is 0.57 and protein is only 88 mg/dL. Timing cannot separate the two, because TB that appears on ART also flares as the CD4 count recovers; what tips the balance is that a flare of the cryptococcal meningitis already diagnosed, in a patient who carried the classic IRIS risk factors, explains the return of the same syndrome with the same raised opening pressure more simply than a second central nervous system pathogen. Mycobacterial studies are still sent because the two can coexist (the trap is chasing a new pathogen suggested by the patient's origin instead of the infection already diagnosed)
  • Relapsed cryptococcal infection — relapse means viable Cryptococcus has returned, proven by a positive CSF culture; this culture is sterile and adherence to fluconazole is confirmed. Cryptococcal antigen clears slowly and stays detectable for months after successful therapy, so a positive titer does not diagnose relapse and serial titers are not used to judge treatment response (the trap is reading persistent antigen as active infection)
  • Drug-induced aseptic meningitis — a sterile meningitis after a new drug is tempting, but antiretrovirals are not among the classic culprits (NSAIDs, trimethoprim-sulfamethoxazole, intravenous immunoglobulin, and lamotrigine); onset is usually within hours to days of starting or restarting the drug and the CSF is often neutrophil-predominant. A flare at the site of a treated infection that tracks CD4 recovery is immune reconstitution, not drug toxicity (the trap is blaming the newest medication)
  • Unmasking cryptococcal IRIS — both forms of IRIS track immune recovery on ART, but unmasking IRIS is the first presentation of an opportunistic infection that was subclinical and untreated when ART began; this meningitis was diagnosed and treated before ART was started, so a flare now is the paradoxical form (the trap is mixing up the two IRIS subtypes)

Additional high-yield points

  • IRIS is a diagnosis of exclusion: repeat the CSF fungal culture and send mycobacterial studies (such as Xpert MTB/RIF Ultra) before settling on it; tuberculosis first diagnosed in the first 3 months of ART is termed ART-associated TB, and unmasking TB IRIS when it presents with an exaggerated inflammatory picture
  • Management: continue ART and fluconazole (do not stop ART), relieve intracranial pressure with therapeutic lumbar punctures when opening pressure is 25 cmH2O or higher, and reserve a short corticosteroid course for severe or life-threatening IRIS; steroids are not routine adjuncts for cryptococcal meningitis itself (harm in the CryptoDex trial)
  • Prevention: defer ART for several weeks after antifungal therapy begins; starting ART 1-2 weeks after diagnosis raised mortality in the COAT trial, and WHO advises a 4-6 week delay
  • If the culture is positive (true relapse), restart induction therapy and test the isolate for fluconazole susceptibility
  • Fluconazole maintenance (200 mg daily) continues for at least 1 year in total and until the CD4 count is 100 cells/mm^3 or higher with suppressed HIV RNA for at least 3 months on ART
Question 10Infectious DiseaseMedium
A 45-year-old female with methicillin-resistant Staphylococcus aureus (MRSA) tricuspid valve endocarditis is being treated with vancomycin. Which of the following is the most appropriate approach to vancomycin therapeutic drug monitoring?
  • ARandom level monitoring
  • BPeak-only monitoring
  • CTime-above-MIC monitoring
  • DAUC24-to-MIC ratio monitoring
  • ETrough-only monitoring
Reveal answer & full explanation
Correct answer: D — AUC24-to-MIC ratio monitoring
  • ARandom level monitoring
  • BPeak-only monitoring
  • CTime-above-MIC monitoring
  • DAUC24-to-MIC ratio monitoring✓
  • ETrough-only monitoring

Why AUC24-to-MIC ratio monitoring is correct

  • The 2020 ASHP/IDSA/SIDP consensus guidelines recommend area-under-the-curve over 24 hours/minimum inhibitory concentration (AUC24/MIC)-guided dosing as standard of care for vancomycin in serious MRSA infection, replacing trough-only monitoring
  • Target AUC24/MIC ratio is 400-600 mg.h/L (assuming MIC 1 mg/L)
  • AUC/MIC correlates with efficacy more reliably than trough; trough-guided dosing required high troughs (15-20) that produced nephrotoxicity in 15-30%
  • AUC is calculated by Bayesian pharmacokinetic software (preferred) using one or two steady-state levels, or by two-point peak-trough kinetics

Why the others are wrong

  • Random level monitoring — untimed levels cannot be related to the dosing interval and do not estimate exposure or guide dosing (confused-with timed sampling)
  • Peak-only monitoring — a single peak misses total drug exposure and was abandoned along with the old peak-trough efficacy targets (anchoring on outdated practice)
  • Trough-only monitoring — the prior standard, now replaced because high troughs (15-20) drove nephrotoxicity without reliably tracking efficacy (right-concept-wrong-metric)
  • Time-above-MIC monitoring — tempting because vancomycin is often described as a time-dependent killer like the beta-lactams, whose target is time above the MIC, but vancomycin efficacy tracks total 24-hour exposure, so the consensus guidelines target AUC24/MIC instead (confused-with beta-lactam pharmacodynamics)

Additional high-yield points

  • Persistent bacteremia after 4-5 days suggests treatment failure — check MIC; switch to daptomycin (6-10 mg/kg/day) or ceftaroline-based combinations if MIC >2 or no response

That's 10 of 7,700+. Get the rest.

Unlock the full FirstPassPA bank: 7,700+ board-style questions across every organ system, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → See today's free PANRE question →

Infectious Disease PANRE practice: FAQ

Are these Infectious Disease PANRE practice questions free?

Yes. Each question shows the full vignette, the correct answer, and a complete explanation, with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, flashcards, and an AI tutor.

How much of the PANRE is Infectious Disease?

Infectious Disease makes up 7% of the PANRE content blueprint. FirstPassPA's timed PANRE exams are dealt to the same weights, so a practice exam carries the same share of Infectious Disease questions.

How should I use these questions?

Attempt each vignette before you reveal the answer, then read the full explanation even when you got it right: the reasons each wrong choice is wrong are where most of the learning is. When you are ready for more, practice Infectious Disease questions in the app, or take a full timed PANRE practice exam dealt to the blueprint weights.

Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.